(November, 2025) Counterfeit drugs pose significant risks to patient safety, potentially containing incorrect ingredients, improper dosages, or harmful substances. To combat this, the Drug Supply Chain Security Act (DSCSA) establishes a framework to enhance the security of the pharmaceutical supply chain in the United States.

Understanding Counterfeit Drugs

• Definition: Counterfeit drugs are medications that are deliberately and fraudulently mislabeled with respect to identity and/or source. They may contain incorrect ingredients, insufficient or excessive amounts of active ingredients, or harmful substances.
• Risks: The use of counterfeit drugs can lead to treatment failure, adverse reactions, or even death. For instance, counterfeit versions of medications like Ozempic have been found in the U.S. drug supply, prompting FDA investigations and warnings to healthcare providers.

The Role of DSCSA in Combating Counterfeit Drugs

The DSCSA, enacted by Congress, aims to protect patients by:

• Establishing a system for tracing drugs: The DSCSA requires the creation of an electronic, interoperable system to trace prescription drugs as they are distributed in the U.S. This system helps identify and remove potentially harmful drugs from the supply chain.
• Enhancing detection and response: By improving the ability to detect and respond to counterfeit drugs, the DSCSA helps prevent these products from reaching patients.
• Ensuring secure transactions: The act mandates that all transactions of drug products covered under DSCSA, where a change of ownership occurs, must be made between authorized trading partners.

Pharmacists’ Responsibilities Under DSCSA

Starting Nov. 27, 2025, drug wholesalers and pharmacies with 26+ full-time employees must be DSCSA compliant. The deadline for pharmacies with 25 or fewer full-time employees is Nov. 27, 2026.

Pharmacists play a crucial role in ensuring the integrity of the drug supply chain by:

• Verifying drug sources: Ensuring that drugs are obtained from authorized trading partners and are accompanied by proper documentation.
• Identifying suspect drugs: Being vigilant for signs of counterfeit drugs, such as unusual packaging or labeling, and reporting any suspicious products to the FDA.
• Maintaining records: Keeping accurate records of drug transactions to facilitate traceability and accountability.

How API Warehouse Protects Pharmacies From Counterfeit Drugs

At API Warehouse, patient safety starts long before a product ever reaches a pharmacy shelf. Our team follows rigorous Drug Supply Chain Security Act (DSCSA) protocols to keep counterfeit or diverted drugs out of the legitimate supply chain. Every step—from receiving to shipping—is designed to verify authenticity and ensure confidence in every order.

1. Secure receiving and inspection
The process begins the moment the product arrives at our dock doors. Each shipment’s address is cross-checked to confirm it matches the verified manufacturer’s shipping location. Our team then performs a detailed physical inspection, examining packaging for damage, inconsistencies or anything unusual. We confirm that every barcode, lot number and serial number is properly displayed and compliant with DSCSA requirements.

2. Paperwork and data verification
Before any product is accepted into inventory, we review all accompanying documentation from the manufacturer to ensure it matches our purchase order. We also confirm receipt of the manufacturer’s electronic product code information services (EPCIS) data—a digital record required under DSCSA. This data allows us to validate what we physically scan against what the manufacturer electronically reported, confirming the integrity of each unit.

3. Pre-shipment validation
Before a product leaves our warehouse, it undergoes another EPCIS data validation. This step ensures that every serial number is legitimate and in the proper status to be transferred to the customer.

4. Safe handling of returns
API Warehouse also manages sellable returns from pharmacies. Each returned item is verified through the Verification Router Service (VRS), which electronically confirms with the manufacturer that the serial number is active, valid and approved for resale.

Protecting patients through precision
Through layered verification—physical, electronic and procedural—API Warehouse ensures that every product distributed meets the highest standards for authenticity and safety. This comprehensive process helps protect our pharmacy partners and, ultimately, the patients who rely on them every day.

Conclusion

Protecting patients from counterfeit drugs requires a collaborative effort among manufacturers, distributors, and healthcare providers. By adhering to DSCSA requirements and remaining vigilant, pharmacists can help safeguard the integrity of the pharmaceutical supply chain and ensure patient safety.